Vaccine Packaging Market- By Packaging Material, Packaging Type Vaccine Type, and End-User & Region - Forecast to 2023-2033
Category: Life Sciences Published Date : May-23 ID: CVC-51921 Format: PDF Pages: 265
Report Highlights According to a research survey conducted by ChemView Consulting, the Vaccine Packaging Market was worth US$ 1.5 Bn. The market is expected to grow at a CAGR of 13.20% between the 2023 and 2033 to reach US$ 5.1 Bn.
Research Scope/Taxonomy:
Key Companies Profiled:
1.1. Global Market Snapshot
1.2. Key Success Factors
1.3. Strategic Analysis and Recommendations
2.1. Market Taxonomy
2.2. Market Definitions
3.1. Preliminary Investigation & Research Design
3.2. Secondary Research & Primary Research
3.3. Data Analysis & Econometric Modelling
3.4. Expert Data Validation
4.1. Supply-Side Trends
4.2. Demand-Side Trends
5.1. Global Market Value (US$ Mn) Analysis, 2017 – 2032
5.2. Incremental $ Opportunity Index, 2022-2032
5.3. Global Market Volume (Tons) Analysis, 2017 – 2032
6.1. Regional Level Pricing Analysis and Forecast
6.1.1. Manufacturers Level Pricing
6.1.2. Distributor Level Pricing
6.2. Global Pricing Analysis Benchmark
6.3. Cost Breakdown Analysis
7.1. Cross Analysis of Packaging Type W.R.T. Packaging Material
8.1. Regional Supply Vs. Demand Gap Assessment
8.2. Top Producing Countries Analysis
9.1. Macroeconomic Factors
9.2. Forecast Factors
9.3. Market Dynamics
9.3.1. Driver
9.3.2. Restraint
9.3.3. Opportunity
9.4. Supply Chain Analysis
9.4.1. List Raw Material Suppliers
9.4.2. List of Manufacturers
9.4.3. List of Distributors
9.4.4. List of End-Users
9.4.5. End-Users Consumption Analysis
9.4.6. Average Profitability Margin Analysis
9.5. Covid-19 Impact Assessment
9.5.1. Economy/Cluster Projections
9.5.2. Covid-19 Economic Assessment
9.5.3. Impact on Target Market
9.5.4. Recovery Scenario
9.6. Regulatory Framework
9.6.1. Regulations of Key Countries
9.6.2. Potential Impact of Regulations
9.7. Porter’s Five Forces Analysis
9.8. Technology Landscape
10.1. Introduction
10.2. Key Market Trends
10.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Packaging Material [Value (US$ Mn) and Volume (Tons) Analysis]
10.3.1. Glass
10.3.2. Plastic
10.3.3. Metal
10.3.4. Others
10.4. Market Attractiveness Analysis by Packaging Material
11.1. Introduction
11.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Packaging Type [Value (US$ Mn) and Volume (Tons) Analysis]
11.2.1. Vials
11.2.2. Ampoules
11.2.3. Syringes
11.2.4. Bottles
11.2.5. Cartridges
11.2.6. Others
11.3. Market Attractiveness Analysis by Packaging Type
12.1. Introduction
12.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Vaccine Type [Value (US$ Mn) and Volume (Tons) Analysis]
12.2.1. COVID-19
12.2.2. Influenza
12.2.3. Measles, Mumps, and Rubella (MMR)
12.2.4. Hepatitis
12.2.5. Polio
12.2.6. Others
12.3. Market Attractiveness Analysis by Vaccine Type
13.1. Introduction
13.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By End User [Value (US$ Mn) and Volume (Tons) Analysis]
13.2.1. Pharmaceutical Companies
13.2.2. Hospitals & Clinics
13.2.3. Research Institutes
13.2.4. Others
13.3. Market Attractiveness Analysis by End User
14.1. Introduction
14.2. Key Market Trends
14.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Region [Value (US$ Mn) and Volume (Tons) Analysis]
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia-Pacific
14.3.5. Middle East
14.3.6. Africa
14.4. Market Attractiveness Analysis by Region
15.1. Introduction
15.2. Key Market Trends
15.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Packaging Material
15.3.3. By Packaging Type
15.3.4. By Vaccine Type
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Packaging Material
15.4.3. By Packaging Type
15.4.4. By Vaccine Type
15.4.5. By End User
16.1. Introduction
16.2. Key Market Trends
16.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Rest of Latin America
16.3.2. By Packaging Material
16.3.3. By Packaging Type
16.3.4. By Vaccine Type
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Packaging Material
16.4.3. By Packaging Type
16.4.4. By Vaccine Type
16.4.5. By End User
17.1. Introduction
17.2. Key Market Trends
17.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. UK
17.3.1.5. Spain
17.3.1.6. Netherlands
17.3.1.7. Norway
17.3.1.8. Russia
17.3.1.9. Rest of Europe
17.3.2. By Packaging Material
17.3.3. By Packaging Type
17.3.4. By Vaccine Type
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Packaging Material
17.4.3. By Packaging Type
17.4.4. By Vaccine Type
17.4.5. By End User
18.1. Introduction
18.2. Key Market Trends
18.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. India
18.3.1.5. Indonesia
18.3.1.6. Thailand
18.3.1.7. Vietnam
18.3.1.8. Australia & New Zealand
18.3.1.9. Rest of Asia-Pacific
18.3.2. By Packaging Material
18.3.3. By Packaging Type
18.3.4. By Vaccine Type
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Packaging Material
18.4.3. By Packaging Type
18.4.4. By Vaccine Type
18.4.5. By End User
19.1. Introduction
19.2. Key Market Trends
19.3. Pricing Analysis
19.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
19.4.1. By Country
19.4.1.1. Saudi Arabia
19.4.1.2. Turkey
19.4.1.3. U.A.E.
19.4.1.4. Rest of the Middle East
19.4.2. By Packaging Material
19.4.3. By Packaging Type
19.4.4. By Vaccine Type
19.4.5. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Packaging Material
19.5.3. By Packaging Type
19.5.4. By Vaccine Type
19.5.5. By End User
20.1. Introduction
20.2. Key Market Trends
20.3. Pricing Analysis
20.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
20.4.1. By Country
20.4.1.1. South Africa
20.4.1.2. Nigeria
20.4.1.3. Egypt
20.4.1.4. Rest of Africa
20.4.2. By Packaging Material
20.4.3. By Packaging Type
20.4.4. By Vaccine Type
20.4.5. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Packaging Material
20.5.3. By Packaging Type
20.5.4. By Vaccine Type
20.5.5. By End User
21.1. Tier Structure Breakdown
21.2. Market Share Analysis
21.3. Production Capacity Analysis
21.4. Company Footprint Analysis
21.4.1. Product Footprint of Players
21.4.2. Regional Footprint of Players
21.4.3. Channel Footprint of Players
21.5. Brand Preference Analysis
21.6. Competition Dashboard
22.1. Schott AG.
22.1.1. Company Overview
22.1.2. Product & Financial Portfolio
22.1.3. Manufacturing Facilities
22.1.4. Recent Developments
22.1.5. SWOT Analysis
22.1.6. Strategy Overview
22.2. Gerresheimer AG
22.3. West Pharmaceutical Services, Inc.
22.4. Becton, Dickinson and Company (BD)
22.5. Amcor plc
22.6. WestRock Company
22.7. SGD Pharma
22.8. SiO2 Materials Science
22.9. Catalent, Inc.
22.10. Stevanato Group
22.11. Bilcare Limited
22.12. Carcano Antonio S.p.A.
22.13. Conservatek Industries Inc.
22.14. DWK Life Sciences
22.15. First Priority Packaging
22.16. Phoenix Packaging Operations
22.17. Unilife Corporation
22.18. Comar, LLC
22.19. Corning Incorporated
22.20. SGI Architectural